Organon Advances Women’s Health Pipeline with US$954 M Forendo Acquisition

By Lucy Haggerty

Pharma Deals Review: Vol 2021 Issue 11 (Table of Contents)

Published: 16 Nov-2021

DOI: 10.3833/pdr.v2021.i11.2646     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

In a bid to strengthen its women’s health portfolio, Organon has agreed to acquire Forendo Pharma in a deal worth up to US$954 M...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details